DOVIPSA Trademark

Trademark Overview


On Thursday, April 5, 2018, a trademark application was filed for DOVIPSA with the United States Patent and Trademark Office. The USPTO has given the DOVIPSA trademark a serial number of 87864686. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 21, 2019. This trademark is owned by Glaxo Group Limited. The DOVIPSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
dovipsa

General Information


Serial Number87864686
Word MarkDOVIPSA
Filing DateThursday, April 5, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 13, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, October 21, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 21, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019EXTENSION 1 GRANTED
Friday, March 8, 2019EXTENSION 1 FILED
Friday, March 8, 2019TEAS EXTENSION RECEIVED
Tuesday, September 18, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 23, 2018ASSIGNED TO PETITION STAFF
Wednesday, August 8, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, July 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 24, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 18, 2018ASSIGNED TO EXAMINER
Friday, April 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 9, 2018NEW APPLICATION ENTERED IN TRAM